Sharon Hemond Hrynkow Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sharon Hemond Hrynkow.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sharon Hemond Hrynkow. Sharon Hemond Hrynkow is a Chief Scientific Officer in CTD HOLDINGS INC ($CTDH) and a SVP for Medical Affairs in CTD HOLDINGS INC ($CTDH).

Address: 4816 KING SOLOMON DRIVE ANNANDALE 22003 VA

Companies in which Sharon Hemond Hrynkow is an Insider

Cyclo Therapeutics, Inc.

Trading Symbol: CTDH
Industry: INDUSTRIAL ORGANIC CHEMICALS [2860]
Position of Sharon Hemond Hrynkow: Chief Scientific Officer, SVP for Medical Affairs
Holdings: 18,350 shares
Current Value: $10,093
Latest Transaction: Mar 30 2021
$CTDH Market Capitalization: $36.82M
$CTDH Previous Close: $0.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Sharon Hemond Hrynkow

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 30 2021CTDHCyclo Therapeutics ...Hrynkow Sharon HemondChief Scientific Of ...BuyP7.461,0007,46018,35017.4 K to 18.4 K (+5.76 %)
Jan 25 2021CTDHCyclo Therapeutics ...Hrynkow Sharon HemondChief Scientific Of ...GrantA0.0010,000017,3507.4 K to 17.4 K (+136.05 %)
Dec 14 2020CTDHCyclo Therapeutics ...Hrynkow Sharon HemondChief Scientific Of ...Option ExerciseP5.001,0005,0001,000
Dec 14 2020CTDHCyclo Therapeutics ...Hrynkow Sharon HemondChief Scientific Of ...GrantA0.001,00007,3506.4 K to 7.4 K (+15.75 %)
Apr 27 2020CTDHCyclo Therapeutics ...Hrynkow Sharon HemondChief Scientific Of ...GrantA0.10200,00020,000635,000435 K to 635 K (+45.98 %)
Sep 30 2019CTDHCTD HOLDINGS INCHrynkow Sharon HemondChief Scientific Of ...GrantA0.00100,0000435,000335 K to 435 K (+29.85 %)
Aug 02 2019CTDHCTD HOLDINGS INCHrynkow Sharon HemondChief Scientific Of ...BuyP0.257,5001,875335,000327.5 K to 335 K (+2.29 %)

View all Sharon Hemond Hrynkow insider transactions.